Your browser is no longer supported. Please, upgrade your browser.
Settings
ACHV Achieve Life Sciences, Inc. daily Stock Chart
ACHV [NASD]
Achieve Life Sciences, Inc.
Index- P/E- EPS (ttm)-1.36 Insider Own1.13% Shs Outstand30.94M Perf Week-0.41%
Market Cap15.21M Forward P/E- EPS next Y-0.22 Insider Trans0.00% Shs Float31.00M Perf Month-2.76%
Income-13.80M PEG- EPS next Q-0.13 Inst Own13.00% Short Float2.81% Perf Quarter-14.94%
Sales- P/S- EPS this Y45.00% Inst Trans-7.86% Short Ratio1.06 Perf Half Y-53.60%
Book/sh0.48 P/B0.85 EPS next Y46.40% ROA-86.40% Target Price- Perf Year-90.35%
Cash/sh- P/C- EPS next 5Y- ROE-104.90% 52W Range0.23 - 4.43 Perf YTD-22.95%
Dividend- P/FCF- EPS past 5Y58.40% ROI- 52W High-90.78% Beta1.79
Dividend %- Quick Ratio8.40 Sales past 5Y- Gross Margin- 52W Low80.87% ATR0.04
Employees14 Current Ratio8.40 Sales Q/Q- Oper. Margin- RSI (14)53.40 Volatility5.94% 10.39%
OptionableNo Debt/Eq0.00 EPS Q/Q87.80% Profit Margin- Rel Volume0.37 Prev Close0.41
ShortableYes LT Debt/Eq0.00 EarningsMay 14 BMO Payout- Avg Volume823.86K Price0.41
Recom1.70 SMA20-1.56% SMA5011.20% SMA200-55.62% Volume304,847 Change0.69%
May-29-20 05:54AM  ACHV: When Quitting Gets You to the Finish Line Zacks Small Cap Research
May-14-20 07:30AM  Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program PR Newswire
May-05-20 08:00AM  Achieve Life Sciences to Announce First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 14, 2020 CNW Group
Apr-30-20 04:50PM  Achieve Life Sciences Announces Private Placement of $1.9 Million PR Newswire
Apr-06-20 05:40AM  ACHV: Extended Treatment May Improve Quit Rates Zacks Small Cap Research
Apr-02-20 08:00AM  Seasoned Biotech Financial Executive, Jay M. Moyes, Joins Sera Prognostics GlobeNewswire
Mar-13-20 08:00AM  Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program PR Newswire -11.79%
08:00AM  Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program CNW Group
Mar-12-20 05:30AM  Achieve Life Sciences Announces Presentation of Additional Cytisinicline Analyses at the Society for Research on Nicotine & Tobacco (SRNT) Annual Meeting PR Newswire -15.86%
Mar-03-20 05:30AM  Achieve Life Sciences to Announce Fourth Quarter and Year-End 2019 Financial Results and Host Conference Call and Webcast on March 13, 2020 CNW Group -5.20%
Feb-06-20 08:00AM  Achieve Life Sciences Announces Agreement with the FreeMind Group to Assist in Securing Non-Dilutive Funding to Evaluate Cytisinicline in Vaping and e-Cigarette Users PR Newswire
Jan-13-20 06:30AM  Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery PR Newswire -7.80%
Dec-23-19 05:31AM  Here's Why We're A Bit Worried About Achieve Life Sciences's (NASDAQ:ACHV) Cash Burn Situation Simply Wall St.
Dec-19-19 04:05PM  Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option PR Newswire
04:05PM  Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option CNW Group
Dec-17-19 01:06PM  Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering PR Newswire -36.49%
01:06PM  Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering CNW Group
Dec-09-19 05:30AM  Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program PR Newswire +14.27%
05:30AM  Achieve Life Sciences Announces Completion of Meeting with the U.S. Food & Drug Administration (FDA) on Cytisinicline Smoking Cessation Phase 3 Clinical Development Program CNW Group
Nov-11-19 10:00AM  ACHV: After Capital Raise Ready for Phase III Zacks Small Cap Research
Nov-06-19 06:30AM  Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program PR Newswire -13.93%
06:30AM  Achieve Reports Financial Results for Third Quarter 2019 and Provides Update on Cytisinicline Development Program CNW Group
Oct-31-19 05:30AM  Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019 CNW Group
Oct-24-19 07:11AM  What Type Of Shareholder Owns Achieve Life Sciences, Inc.'s (NASDAQ:ACHV)? Simply Wall St.
05:30AM  Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference PR Newswire
05:30AM  Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference CNW Group
Sep-30-19 05:30AM  Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study PR Newswire -9.57%
Sep-25-19 06:30AM  ACHV: Post Phase II Investor Day Zacks Small Cap Research
Sep-13-19 05:30AM  Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference PR Newswire
Sep-09-19 10:34AM  What Kind Of Share Price Volatility Should You Expect For Achieve Life Sciences, Inc. (NASDAQ:ACHV)? Simply Wall St.
Sep-05-19 05:30AM  Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial PR Newswire +5.71%
Sep-04-19 05:30AM  Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences PR Newswire +5.53%
Aug-26-19 02:30PM  ACHV: SRNT Presentation Next on Agenda Zacks Small Cap Research
10:30AM  ACHV: SRNT Presentation Next on Agenda Zacks Small Cap Research
Aug-08-19 05:39PM  /C O R R E C T I O N -- Achieve Life Sciences, Inc./ PR Newswire +5.71%
04:05PM  Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update CNW Group
Jul-30-19 05:30AM  Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 PR Newswire
05:30AM  Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 CNW Group
Jul-23-19 05:30AM  Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation PR Newswire
Jul-10-19 10:47AM  Did You Manage To Avoid Achieve Life Sciences's (NASDAQ:ACHV) Painful 55% Share Price Drop? Simply Wall St.
Jun-21-19 10:38AM  Achieve Life Sciences Says Mid-Stage Data For Smoking Cessation Drug Accepted For Presentation At Conference Benzinga
05:30AM  Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference PR Newswire
Jun-12-19 01:00PM  ACHV: ORCA-1 Topline Results and Comparison Zacks Small Cap Research -8.62%
Jun-11-19 07:00AM  Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial PR Newswire -25.26%
07:00AM  Achieve Life Sciences Announces Statistically Significant Improvement in Quit Rates for Simplified Cytisinicline Dosing Schedule in Phase 2b ORCA-1 Dose-Selection Trial CNW Group
Jun-03-19 04:05PM  Achieve Receives $4.2 Million from Exercise of Warrants PR Newswire
04:05PM  Achieve Receives $4.2 Million from Exercise of Warrants CNW Group
May-30-19 02:00PM  ACHV: 1Q:19 Financial & Operational Update Zacks Small Cap Research
05:30AM  Achieve Announces Patent Granted in the U.S. for Novel Formulation of Cytisinicline PR Newswire
May-15-19 04:05PM  Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update PR Newswire
04:05PM  Achieve Reports Financial Results for First Quarter 2019 and Provides Cytisinicline Clinical Development Update CNW Group
May-07-19 05:30AM  Achieve Life Sciences to Announce First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 15, 2019 PR Newswire
Apr-26-19 10:00AM  ACHV: Final Enrollee, Final Visit Zacks Small Cap Research +8.21%
Apr-24-19 05:30AM  Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Apr-03-19 05:30AM  Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019 PR Newswire +5.64%
Apr-02-19 07:30AM  The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial Benzinga
05:30AM  Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation PR Newswire
Mar-25-19 10:00AM  ACHV: Fiscal Year 2018 Operational and Financial Results Zacks Small Cap Research +6.71%
Mar-18-19 08:35AM  What Do the Clinical Updates at Achieve Life Sciences Mean for Cytisinicline ACCESSWIRE +5.32%
05:30AM  Achieve Life Sciences to Present at Oppenheimer's 29th Annual Healthcare Conference on March 20, 2019 PR Newswire
Mar-15-19 04:05PM  Four Healthcare Stocks Picking Up Speed On Friday ACCESSWIRE +22.86%
Mar-14-19 04:05PM  Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update PR Newswire
Mar-12-19 01:00PM  ACHV: A Reason to Quit is a Reason to Buy Zacks Small Cap Research
Mar-05-19 05:30AM  Achieve Life Sciences to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call and Webcast on March 14, 2019 PR Newswire
Feb-28-19 09:00AM  Predictive Technology Group Names Jay M. Moyes to Its Board of Directors GlobeNewswire
Feb-25-19 10:30AM  Healthcare Stocks Leading the Sector ACCESSWIRE -19.70%
06:26AM  Could The Achieve Life Sciences, Inc. (NASDAQ:ACHV) Ownership Structure Tell Us Something Useful? Simply Wall St.
Feb-22-19 10:40AM  Four Healthcare Stocks Looking to Close Out a Strong Week ACCESSWIRE +84.36%
08:36AM  Achieve Life Sciences' stock rockets on heavy volume after update results of smoking-cessation drug trial MarketWatch
05:30AM  Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting PR Newswire
Feb-20-19 05:30AM  Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b Trial of Cytisinicline for Smoking Cessation PR Newswire -9.20%
Dec-28-18 07:06AM  5 Top Rising P/E Stocks to Enjoy Solid Gains Zacks
Dec-18-18 05:30AM  Achieve Announces Update on Cytisinicline Clinical Development Program PR Newswire -5.93%
Nov-29-18 08:06AM  Zacks.com highlights: Asbury Automotive, OncoGenex Pharmaceuticals, aTyr Pharma, Avinger and Sunesis Pharmaceuticals Zacks -6.63%
Nov-28-18 07:04AM  5 Top-Ranked Rising P/E Stocks to Lure Investors Zacks
Nov-07-18 04:05PM  Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update PR Newswire
Oct-31-18 05:30AM  Achieve Life Sciences to Announce Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 7, 2018 PR Newswire
Oct-30-18 09:45AM  3 Healthcare Stocks that Could Move on Industry Growth ACCESSWIRE
05:30AM  Achieve Life Sciences Announces Initiation of Phase 2b ORCA-1 Trial Evaluating Cytisinicline (cytisine) for Smoking Cessation PR Newswire
Oct-03-18 12:41PM  Achieve Life Sciences Stock Will Probably Tumble Further InvestorPlace
Oct-01-18 09:05AM  Achieve Announces Pricing of $5.6 Million Registered Direct Offering PR Newswire -15.24%
Sep-27-18 08:56AM  Achieve Life Sciences' stock rockets on positive study results for smoking cessation drug MarketWatch +39.56%
05:30AM  Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects PR Newswire
Sep-26-18 05:30AM  Achieve to Present at the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018 PR Newswire
Sep-18-18 05:30AM  Achieve Announces Positive Cytisine Data Published in International Journal of Drug Policy PR Newswire
Sep-06-18 05:30AM  Achieve Life Sciences Announces Cytisine Data Presented at the Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Conference PR Newswire
Sep-05-18 05:30AM  Achieve to Present at the H.C. Wainwright 20th Annual Global Investment Conference on September 6, 2018 PR Newswire
Aug-08-18 04:05PM  Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update PR Newswire
Aug-02-18 05:30AM  Achieve Life Sciences to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 8, 2018 PR Newswire
Jul-12-18 08:00AM  Today's Research Reports on Stocks to Watch: Achieve Life Sciences and Pfizer ACCESSWIRE -9.25%
Jul-11-18 10:52AM  Achieve Life Sciences Shares Surge On Development Plan For Smoking Cessation Candidate Benzinga +10.50%
05:30AM  Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA PR Newswire
Jun-27-18 08:00AM  Todays Research Reports on Stocks to Watch: Puma Biotechnology and Achieve Life Sciences ACCESSWIRE -19.80%
Jun-26-18 11:41AM  Achieve Life Sciences Shares Rip Higher On Positive Data For Smoking Cessation Drug Benzinga +34.21%
05:30AM  Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction PR Newswire
Jun-19-18 04:01PM  Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option PR Newswire
Jun-15-18 08:30AM  Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering PR Newswire -29.81%
Jun-11-18 05:30AM  Achieve Announces Publication of Cytisine Data for Next-Generation Cytisine Molecules PR Newswire
May-25-18 06:09PM  Should You Be Concerned About Achieve Life Sciences Incs (NASDAQ:ACHV) Shareholders? Simply Wall St.
May-23-18 05:30AM  Achieve Life Sciences, Inc. Announces Reverse Stock Split PR Newswire -9.91%
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. Its product candidate include cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. The company has license agreements with Sopharma AD and University of Bristol; and a strategic collaboration with National Institutes of Health for the development of cytisinicline for smoking cessation. Achieve Life Sciences, Inc. was incorporated in 1991 and is based in Vancouver, Canada.